Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goujard

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 31, 2006
[Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study]S Fridmann, F Boufassa, I Cartier, et al.
HIV Clinical Trials|October 9, 2001
Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological responseF Boufassa, A Dulioust, A S Lascaux, et al.
AIDS (London, England)|May 1, 1995
Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infectionS Lamhamedi-Cherradi, B Culmann-Penciolelli, B Guy, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomasA S Lascaux, F Hemery, C Goujard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progressionM L Gougeon, H Lecoeur, A Dulioust, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 22, 2013
Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infectionP Frange, L Meyer, J Ghosn, et al.
Rapid Communications in Mass Spectrometry : RCM|August 17, 2001
Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometryA Pruvost, F Becher, P Bardouille, et al.
AIDS (London, England)|December 28, 2000
CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patientsS Guérin, L Meyer, I Theodorou, et al.
AIDS (London, England)|April 15, 1999
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 31, 2006
[Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study]S Fridmann, F Boufassa, I Cartier, et al.
HIV Clinical Trials|October 9, 2001
Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological responseF Boufassa, A Dulioust, A S Lascaux, et al.
AIDS (London, England)|May 1, 1995
Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infectionS Lamhamedi-Cherradi, B Culmann-Penciolelli, B Guy, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomasA S Lascaux, F Hemery, C Goujard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progressionM L Gougeon, H Lecoeur, A Dulioust, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 22, 2013
Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infectionP Frange, L Meyer, J Ghosn, et al.
Rapid Communications in Mass Spectrometry : RCM|August 17, 2001
Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometryA Pruvost, F Becher, P Bardouille, et al.
AIDS (London, England)|December 28, 2000
CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patientsS Guérin, L Meyer, I Theodorou, et al.
AIDS (London, England)|April 15, 1999
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.
Pageof 8